Personal follow-up of 100 aortic valve replacement patients for 1081 patient years

Annales Chirurgiae et Gynaecologiae

Volumn 87, Issue 3, 1998, Pages 205-212

  Varstela, E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Aortic valve surgery; Consecutive; Follow up; Mechanical valve

Indexed keywords

ADULT; AGED; ANTICOAGULATION; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; EMBOLISM; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; REOPERATION;

ADULT; AGED; ANTICOAGULANTS; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; SURVIVAL ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 30344441568     PISSN: 03559521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Varstela E, Verkkala K, Turto H: Periprosthetic leakage after-aortic valve replacement. Ann Chir Gyn 83: 210-217, 1994
2. Edmunds LH, Clark RE, Cohn LH, Miller DC, Weisel RD: Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 46: 257-259, 1988
3. Gardner MJ, Altman DG (Eds): Statistics with confidence. 1st ed. London: Br Med J: 28-30, 70-76, 1989
4. Armitage P, Berry G: Statistical methods in medical research. 3rd ed. Oxford: Blackwell scientific publications, 1994, pp. 97-99.
5. Borkon AM, Soule L, Baughman KL, Aoun H, Gardner TJ, Watkins L Jr, Baumgartner WA, Gott VL, Reitz BA: Ten-year analysis of the Björk-Shiley standard aortic valve. Ann Thorac Surg 43: 39-51, 1987
6. Janatuinen MJ, Vänttinen EA, Rantakokko V, Inberg M: Early and late results of aortic valve replacement. Scand J Thorac Cardiovasc Surg 25: 119-125, 1991
7. Cohn LH, Allred EN, DiSesa VJ, Sawtelle K, Shemin RJ, Collins JJ: Early and late risk of aortic valve replacement. J Thorac Cardiovasc Surg 88: 695-705, 1984
8. Meurs AAH, Gründemann AM, Bezemer PD, Geldof WChP, Zienkowicz BS, Ong ST, DeJong IH: Early and 8 year results of aortic valve replacement: a clinical study of 232 patients. Eur Heart 6: 870-881, 1985
9. DiLello F, Flemma RJ, Anderson AJ, Mullen DC, Kleinman LH, Werner PH: Improved early results after aortic valve replacement: Analysis by surgical time frame. Ann Thorac Surg 47: 51-56, 1989
10. Saour JN, Sieck JO, Mamo LAR, Gallus AS: Trial of different intensities of anticoagulation in patients with prosthetic heart valves. New Engl J Med 322: 428-432, 1990
11. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM: Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Circulation 84 (Suppl III): 61-69, 1991
12. Wilson DB, Dunn MI, Hassanein K: Low-intensity anticoagulation in mechanical cardiac prosthetic valves. Chest 100: 1553-1557, 1991
13. Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, Chow J, Ng RP, Tse TF: Warfarin versus dipyridamole-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation 72: 1059-1063, 1985
14. Myers ML, Lawrie GM, Crawford ES, Howell JF, Morris GCJr, Glaeser DH, DeBakey ME: The St. Jude valve prosthesis: Analysis of the clinical results in 815 implants and the need for systemic anticoagulation. J Am Coll Cardiol 13: 57-62, 1989
15. Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV: Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 51: 1537-1541, 1983
16. Altman R, Rouvier J, Gurfinkel E, D'Ortencio O, Manzanel R, de La Fuente L, Favaloro RG: Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 101: 427-431, 1991
17. Turpie AGG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J: A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. New Engl J Med 329: 524-529, 1993
18. Gohlke-Bärwolf C, Acar J, Burckhardt D, Oakley C, Butchart E, Krayenbühl P, Hall R, Bodbar E, Krzeminska-Pakula M, Delahaye J-P, Samama M: Guidelines for prevention of thromboembolic events in valvular heart disease. J Heart Valve Dis 2: 398-410, 1993
19. Acar J, Iung B, Boissel JB, Samama MM, Michel PL, Teppe JP, Pony JC, Breton HL, Thomas D, Isnard R, de Gevigney G, Viguier E, Sfihi A, Hanania G, Ghannem M, Mlrode A, Nemoz C: AREV A: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 94: 2107-2112, 1996
20. Stewart S, Cianciotta D, Hicks GL, DeWeese JA: The Lillehei-Kaster aortic valve prosthesis. Long-term results in 273 patients with 1253 patient-years of follow-up. J Thorac Cardiovasc Surg 95: 1023-1030, 1988
21. Milano AD, Bortoloti U, Mazzucco A, Guerra F, Magni A, Callucci V: Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. J Thorac Cardiovasc Surg 98: 37-47, 1989
22. Vallejo JL, Gonzales-Santos JM, Albertos J, Riesgo MJ, Bastida ME, Rico MJ, Gonzales-Diego F, Areas R: Eight years' experience with the Medtronic-Hall valve prosthesis. Ann Thorac Surg 50: 429-436, 1990
23. Olesen KH, Rygg IH, Wennevold A, Nyboe J: Aortic valve replacement with the Lillehei-Kaster prosthesis in 262 patients: An assessment after 9 to 17 years. Eur Heart J 12: 680-689, 1991
24. Orszulak TA, Schaff HV, DeSmet J-M, Danielson GK, Pluth JR, Puga FJ: Late results of valve replacement with the Björk-Shiley valve (1973 to 1982). J Thorac Cardiovasc Surg 105: 302-312, 1993
25. Kratz JM, Crawford Jr. FA, Sade RM, Crumbley AJ, Stroud MR: St. Jude prosthesis for aortic and mitral valve replacement: A ten-year experience. Ann Thorac Surg 56: 462-468, 1993
26. Aagaard J, Hansen CN, Tingleff J, Rygg I: Seven-and-a-half years clinical experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 4: 628-433, 1995
27. Baudet EM, Puel V, McBride JT, Grimaud J-P, Roques F, Clerc F, Roques X, Laborde N: Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 109: 858-870, 1995
28. Nistal JF, Hurlé A, Revuelta JM, Candarillas M: Clinical experience with the CarboMedics valve:early results with a new bile-aflet mechanical prosthesis. J Thorac Cardiovasc Surg 112: 59-68, 1996
29. Czer LSC, Chaux A, Matloff JM, DeRobertis MA, Nessim SA, Scarlata D, Khan SS, Kass RM, Tsai TP, Blanche C, Gray RJ: Tenyear experience with the St. Jude Medical valve for primary valve replacement. J Thorac Cardiovasc Surg 100: 44-55, 1990
30. Ibrahim M, O'Kane H, Cleland J, Gladstone D, Sarsam M, Patterson C: The St. Jude Medical prosthesis. A thirteen-year experience. J Thorac Cardiovasc Surg 108: 221-230, 1994
31. Nitter-Hauge S, Abdelnoor M, Svennevig JL: Fifteen-year experience with the Medtronic-Hall valve prosthesis. A follow-up study of 1104 patients. Circulation 94 (suppl II): 105-108, 1996
32. Aoyagi S, Oryoji A, Nishi Y, Tanaka K, Kosuga K, Oishi K: Long-term results of valve replacement with the St. Jude Medical valve. J Thorac Cardiovasc Surg 108: 1021-1029, 1994
33. Akins CW: Long-term results with the Medtronic-Hall valvular prosthesis. Ann Thorac Surg 61: 806-813, 1996
34. Lindblom D, Lindblom U, Qvist J, Lundström H: Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol 15: 566-573, 1990
35. Abdelnoor M, Nitter-Hauge S, Trettli S: Relative survival of patients after heart valve replacement. Eur Heart J 11: 23-28, 1990